RVMD.W - Revolution Medicines, Inc. - Equity Warrant Stock - Stock Price, Institutional Ownership, Shareholders (NasdaqGS)

Revolution Medicines, Inc. - Equity Warrant
THIS SYMBOL IS NO LONGER ACTIVE

Basic Stats
Institutional Owners 33 total, 33 long only, 0 short only, 0 long/short - change of -2.94% MRQ
Average Portfolio Allocation 0.0043 % - change of 996.46% MRQ
Institutional Shares (Long) 8,181,546 (ex 13D/G) - change of 0.38MM shares 4.86% MRQ
Institutional Value (Long) $ 2,039 USD ($1000)
Institutional Ownership and Shareholders

Revolution Medicines, Inc. - Equity Warrant (US:RVMD.W) has 33 institutional owners and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 8,181,546 shares. Largest shareholders include LMR Partners LLP, D. E. Shaw & Co., Inc., Price T Rowe Associates Inc /md/, Adage Capital Partners Gp, L.l.c., Lunate Capital Ltd, Soros Capital Management Llc, Aristeia Capital Llc, PRNHX - T. Rowe Price New Horizons Fund, Inc., Perceptive Advisors Llc, and Toronto Dominion Bank .

Revolution Medicines, Inc. - Equity Warrant (NasdaqGS:RVMD.W) institutional ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds (or held) more than 5% of the company and intends (or intended) to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%.

RVMD.W / Revolution Medicines, Inc. - Equity Warrant Institutional Ownership
Fund Sentiment Score

The Fund Sentiment Score (fka Ownership Accumulation Score) finds the stocks that are being most bought by funds. It is the result of a sophisticated, multi-factor quantitative model that identifies companies with the highest levels of institutional accumulation. The scoring model uses a combination of the total increase in disclosed owners, the changes in portfolio allocations in those owners and other metrics. The number ranges from 0 to 100, with higher numbers indicating a higher level of accumulation to its peers, and 50 being the average.

Update Frequency: Daily

See Ownership Explorer, which provides a list of highest-ranking companies.

Institutional Put/Call Ratio

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

RVMD.W / Revolution Medicines, Inc. - Equity Warrant Historical Put/Call Ratio
13F and NPORT Filings

Detail on 13F filings are free. Detail on NP filings require a premium membership. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

File Date Source Investor Type Avg Price
(Est)
Shares Δ Shares
(%)
Reported
Value
($1000)
Δ Value
(%)
Port Alloc
(%)
2025-08-14 13F Royal Bank Of Canada 200 0.00 0
2025-05-13 13F UBS Group AG 0 -100.00 0
2025-05-15 13F Marshall Wace, Llp Call 0 -100.00 0
2025-08-26 NP PRHSX - T. Rowe Price Health Sciences Fund, Inc. This fund is a listed as child fund of Price T Rowe Associates Inc /md/ and if that institution has disclosed ownership in this security, then these positions will not be double counted when calculating total shares and total value 198,505 0.00 54 657.14
2025-08-14 13F Millennium Management Llc Call 86,828 0.00 23 633.33
2025-07-17 13F Lunate Capital Ltd 450,000 118
2025-08-26 NP EQ ADVISORS TRUST - EQ/T. Rowe Price Health Sciences Portfolio Class IB 3,127 0.00 1
2025-06-25 NP TMSRX - T. Rowe Price Multi-Strategy Total Return Fund This fund is a listed as child fund of Price T Rowe Associates Inc /md/ and if that institution has disclosed ownership in this security, then these positions will not be double counted when calculating total shares and total value 2,200 0.00 0
2025-04-28 NP John Hancock Funds II - Health Sciences Fund Class NAV 6,524 0.00 1 -100.00
2025-07-09 13F DLK Investment Management, LLC 164,477 113.61 43 2,050.00
2025-08-14 13F Aristeia Capital Llc 313,031 -1.91 74 329.41
2025-08-14 13F Bleichroeder LP 200,000 0.00 53 642.86
2025-08-14 13F Toronto Dominion Bank 221,363 -0.14 58 625.00
2025-08-14 13F Perceptive Advisors Llc 250,000 0.00 66 622.22
2025-08-04 13F Wolverine Asset Management Llc 70,349 0.00 18 800.00
2025-08-13 13F Clear Street Llc 0 -100.00 0
2025-08-14 13F D. E. Shaw & Co., Inc. 1,454,895 0.00 393 612.73
2025-08-14 13F Cantor Fitzgerald, L. P. 109,617 0.00 29 600.00
2025-05-15 13F Magnetar Financial LLC 0 -100.00 0
2025-08-14 13F Css Llc/il 35,847 -30.24 85 394.12
2025-08-12 13F Proequities, Inc. 0 0
2025-08-26 NP PRNHX - T. Rowe Price New Horizons Fund, Inc. This fund is a listed as child fund of Price T Rowe Associates Inc /md/ and if that institution has disclosed ownership in this security, then these positions will not be double counted when calculating total shares and total value 302,672 0.00 82 636.36
2025-07-28 13F Td Asset Management Inc 40,636 0.00 11 900.00
2025-05-15 13F Boothbay Fund Management, Llc 0 -100.00 0
2025-08-13 13F Walleye Capital LLC 0 -100.00 0
2025-08-14 13F Soros Capital Management Llc 364,824 0.00 96 630.77
2025-08-26 NP QAAGZX - T. Rowe Price Health Sciences Portfolio This fund is a listed as child fund of Price T Rowe Associates Inc /md/ and if that institution has disclosed ownership in this security, then these positions will not be double counted when calculating total shares and total value 11,096 0.00 3
2025-08-11 13F TD Waterhouse Canada Inc. 448 0.00 0
2025-08-25 NP MMBUX - MassMutual Select T. Rowe Price Small and Mid Cap Blend Fund Class I 1,166 0.00 0
2025-07-22 NP DMSFX - Destinations Multi Strategy Alternatives Fund Class I 88,320 0.00 9 28.57
2025-09-04 13F/A Advisor Group Holdings, Inc. 64 0.00 0
2025-08-14 13F Davidson Kempner Capital Management Lp 150,000 0.00 39 680.00
2025-08-14 13F Weiss Asset Management LP 73,640 0.00 20 850.00
2025-08-14 13F Driehaus Capital Management Llc 135,000 0.00 36 620.00
2025-08-14 13F Adage Capital Partners Gp, L.l.c. 500,000 0.00 131 589.47
2025-08-14 13F Sculptor Capital LP 178,107 0.00 42 355.56
2025-08-14 13F Price T Rowe Associates Inc /md/ 599,301 0.00 0
2025-08-14 13F LMR Partners LLP 2,646,023 1.51 695 602.02
2025-08-14 13F Farallon Capital Management Llc 120,085 0.00 32 700.00
2025-08-29 NP JAFMX - Health Sciences Trust NAV 4,502 0.00 1
Other Listings
US:RVMDW $0.20
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista